Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation

Fig. 1

Unsupervised CIA of the PC-3 cell lines. A gene/transcription factor binding site (TFBS) frequency table produced with a position-specific scoring matrix (PSSM) threshold of 0.85 was used. a: The projection of the samples shows a clear separation between the parental and the two docetaxel resistant cell lines. b: The projection of the TFBS motifs is shown. Motifs that are in the same orientation as the docetaxel resistant cell lines in Fig. 1a are associated with docetaxel-resistance

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us